EYETRONIC
Company
EYETRONIC develops one asset, in human trials (Eyetronic rtACS in glaucoma). Mostly device.
- 1
- Asset
- Furthest stage
- Human trials
- 0
- Trials
- 1
- Signal
Pipeline
1Applies transorbital alternating current stimulation to enhance visual function in glaucoma.
Human trials, Device, glaucoma, glaucoma open-angle
Full company profiles: pipeline, trials, funding and people.
In the full profile
- Trials1
- Signals1
- Similar companies4